Intellectual Property Office Home University of Cincinnati
News
Technologies
Issued US Patents
UC Technology Startups
Forms
Our Mission
IP Overview
Patents
Copyright
Licensing
Conflicts
Policies and Law
Annual Reports
Staff and Location
Contact Us
Links
UC Directory
IPO Home

Case Number 099039 - Polymorphisms Related to Beta2 Adrenergic Receptor

Description:  Research at the University of Cincinnati has identified genetic alterations in the beta-2 adrenergic receptor that support a method for predicting an individual's response to the .beta.-agonists salmeterol, albuterol, metaproterenol, terbutaline and formoterol. Individuals expressing the Ile164 .beta..sub.2 AR variant are likely to exhibit a reduced response as compared to individuals expressing the Thr164 .beta..sub.2 AR variant. The method is useful for making treatment decisions for patients suffering from asthma and chronic obstructive pulmonary diseases.

Issued US Patents 6,797,472 and 6,861,217


For more information please contact Kellen Sensor at 513-558-5621 or Kellen.Sensor@uc.edu



Back to Technologies
 
Printer Friendly Version of Polymorphisms Related to Beta2 Adrenergic Receptor - 099039









Copyright Information © Copyright 2004-2012 university of Cincinnati, Ohio. All rights reserved.